Advertisement

Topics

Swiss biotech firm gains $54.8M in funding from BARDA

05:22 EDT 14 Jun 2017 | SmartBrief

Under its existing contract with the Biomedical Advanced Research and Development Authority, Basilea Pharmaceutica of Switzer -More

Original Article: Swiss biotech firm gains $54.8M in funding from BARDA

NEXT ARTICLE

More From BioPortfolio on "Swiss biotech firm gains $54.8M in funding from BARDA"

Quick Search
Advertisement